Navigating the Purification Process: Maintaining the Integrity of Replication-Competent Enveloped Viruses
Open Access
Abstract
Replication-competent virus particles hold significant therapeutic potential in application as oncolytic viruses or cancer vaccines. Ensuring the viral integrity of these particles is crucial for their infectivity, safety, and efficacy. Enveloped virus particles, in particular, offer large gene insert capacities and customizable target specificity. However, their sensitivity to environmental factors presents challenges in bioprocessing, potentially compromising high quality standards and cost-effective production. This review provides an in-depth analysis of the purification process steps for replication-competent enveloped virus particles, emphasizing the importance of maintaining viral integrity. It evaluates bioprocessing methods from cell culture harvest to final sterile filtration, including centrifugation, chromatographic, and filtration purification techniques. Furthermore, the manuscript delves into formulation and storage strategies necessary to preserve the functional and structural integrity of virus particles, ensuring their long-term stability and therapeutic efficacy. To assess the impact of process steps on particles and determine their quality and integrity, advanced analytical methods are required. This review evaluates commonly used methods for assessing viral integrity, such as infectious titer assays, total virus particle quantification, and structural analysis. By providing a comprehensive overview of the current state of bioprocessing for replication-competent enveloped virus particles, this review aims to guide researchers and industry professionals in developing robust and efficient purification processes. The insights gained from this analysis will contribute to the advancement of virus-based therapeutics, ultimately supporting the development of safe, effective, and economically viable treatments for various diseases.Keywords
This publication has 283 references indexed in Scilit:
- Development, optimization, and scale‐up of suspension Vero cell culture process for high titer production of oncolytic herpes simplex virus‐1Biotechnology Journal, 2023
- Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector ProductionBiotechnology Journal, 2020
- Purification of cell‐derived Japanese encephalitis virus by dual‐mode chromatographyBiotechnology and Applied Biochemistry, 2020
- Large‐scale purification of high purity α1‐antitrypsin from Cohn Fraction IV with virus inactivation by solvent/detergent and dry‐heat treatmentBiotechnology and Applied Biochemistry, 2017
- Defective interfering viruses and their impact on vaccines and viral vectorsBiotechnology Journal, 2015
- Flow‐dependent entrapment of large bioparticles in porous process mediaBiotechnology and Bioengineering, 2009
- A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatographyBiotechnology and Bioengineering, 2005
- Affinity capture of a biotinylated retrovirus on macroporous monolithic adsorbents: Towards a rapid single‐step purification processBiotechnology and Bioengineering, 2005
- Absorption and Scattering of Light by Small Particles1998
- The primary production of an infectious recombinant Herpes Simplex Virus vaccineBiotechnology and Bioengineering, 1998